Godavari Drugs share news and announcements
BSE: 530317Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹124.15.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹122 Cr3,042nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 29.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 1.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 7.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 4.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 1.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,422
Godavari Drugs share news and announcements
547 announcements, routine notices left out, newest first. Page 3 of 11.
Feb 2024
Nov 2023
15 Nov · Regarding Lease Of Land In Kushnoor Industrial Area, Nanded Maharastra
7 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results
Aug 2023
4 Aug · Board meeting
Meeting on 11 Aug 2023: quarterly results
Jul 2023
Jun 2023
May 2023
29 May · Results
23 May · Board meeting
Meeting on 29 May 2023: audited results
Apr 2023
20 Apr · Compliance For The Quarter Ended March 31, 2023.
7 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI LODR , 2015 For 31.03.2023
7 Apr · Transmision Of Shares Of Mangla Shrimal Belonging To The Promoter Group In The Name Of Her Son Mr. Prashant Shrimal.
Mar 2023
Feb 2023
3 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Jan 2023
Dec 2022
30 Dec · Intimation For Change In Designation Of Director Under Regulation 30 (2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
30 Dec · Intimation For Change In Designation Of Director Under Regulation 30 (2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
28 Dec · Intimation For Change In Designation Of Director Under Regulation 30 (2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015